[New post] Intranasal booster trials get DCGI nod

IASbaba posted: "Intranasal booster trials get DCGI nod Part of: Prelims and GS-II Health Context: The Drugs Controller General of India (DCGI) has given vaccine manufacturer Bharat Biotech approval for conducting Phase 3 clinical trials of an intranasal booster dose fo" New post on IASbaba Intranasal booster trials get DCGI nod by IASbaba Intranasal booster trials get DCGI nod Part of: Prelims and GS-II Health Context: The Drugs Controller General of India (DCGI) has given vaccine manufacturer Bharat Biotech approval for conducting Phase 3 clinical trials of an intranasal booster dose for those who have received both doses of Covaxin. The chimpanzee adenovirus vectored COVID-19 vaccine (BBV154) will […] Read more of this post IASbaba | January 29, 2022 at 1:34 pm | URL: https://iasbaba.com/?p=133950 Comment    See all comments Unsubscribe to no longer receive posts from IASbaba. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://iasbaba.com/2022/01/intranasal-booster-trials-get-dcgi-nod/